BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15202175)

  • 1. A costly conflict. Hospitals should take a stand against dirty deals with drug, device firms.
    Sloane T
    Mod Healthc; 2004 May; 34(22):20. PubMed ID: 15202175
    [No Abstract]   [Full Text] [Related]  

  • 2. Inducements by Pharmaceutical Companies: The Elephant in the Room.
    Soans ST
    Indian Pediatr; 2018 Aug; 55(8):649-651. PubMed ID: 30218507
    [No Abstract]   [Full Text] [Related]  

  • 3. Doctors and drug companies.
    Lambert LA
    N Engl J Med; 2005 Feb; 352(7):733-4; author reply 733-4. PubMed ID: 15716575
    [No Abstract]   [Full Text] [Related]  

  • 4. Industry support and professional medical associations.
    Jackson RH
    JAMA; 2009 Aug; 302(7):738; author reply 739. PubMed ID: 19690304
    [No Abstract]   [Full Text] [Related]  

  • 5. Taking money from the drug industry: the rules tighten.
    Elliott C
    Hastings Cent Rep; 2003; 33(4):6-7. PubMed ID: 12971053
    [No Abstract]   [Full Text] [Related]  

  • 6. The physician and the pharmaceutical industry: both must keep the patient's interests at heart.
    Ravindran GD
    Issues Med Ethics; 1999; 7(1):21-2. PubMed ID: 16320467
    [No Abstract]   [Full Text] [Related]  

  • 7. Too friendly? Teaching hospitals revisit ties to pharmaceutical firms.
    Romano M
    Mod Healthc; 2003 Jul; 33(28):17. PubMed ID: 12884711
    [No Abstract]   [Full Text] [Related]  

  • 8. The ethics of pharmaceutical industry gift-giving: the role of a professional association.
    Morin K; Morse LJ
    Am J Bioeth; 2003; 3(3):54-5. PubMed ID: 14594494
    [No Abstract]   [Full Text] [Related]  

  • 9. Industry support and professional medical associations.
    Smith CD; Buyske J; Talamini MA
    JAMA; 2009 Aug; 302(7):738-9; author reply 739. PubMed ID: 19690303
    [No Abstract]   [Full Text] [Related]  

  • 10. A quiz on "the ethics of accepting gifts from industry".
    Holm RP;
    S D Med; 2007 Mar; 60(3):117-8. PubMed ID: 17455581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PhRMA's Code on Interactions with Healthcare Professionals.
    Bieri D
    Am J Bioeth; 2010 Oct; 10(10):18. PubMed ID: 20945263
    [No Abstract]   [Full Text] [Related]  

  • 12. Doctors and drug companies.
    Blumenthal D
    N Engl J Med; 2004 Oct; 351(18):1885-90. PubMed ID: 15509823
    [No Abstract]   [Full Text] [Related]  

  • 13. Academic medical centers and conflicts of interest.
    Meador KJ
    JAMA; 2006 Jun; 295(24):2845; author reply 2848-9. PubMed ID: 16804144
    [No Abstract]   [Full Text] [Related]  

  • 14. German doctors free to take cash from drug firms.
    Hyde R
    Lancet; 2012 Aug; 380(9841):551. PubMed ID: 22891373
    [No Abstract]   [Full Text] [Related]  

  • 15. Resident and fellow section. Conflicts of interest between physicians and the pharmaceutical industry: focus on headache medicine.
    Rubin EB; Bernat JL
    Headache; 2008; 48(10):1545-9. PubMed ID: 19076654
    [No Abstract]   [Full Text] [Related]  

  • 16. Academic medical centers and conflicts of interest.
    Watson PY; Musial JL; Khandewal AK; Buckley JD
    JAMA; 2006 Jun; 295(24):2847-8; author reply 2848-9. PubMed ID: 16804147
    [No Abstract]   [Full Text] [Related]  

  • 17. The gift of drug samples.
    Reid EE
    Hastings Cent Rep; 2012; 42(2):49. PubMed ID: 22733332
    [No Abstract]   [Full Text] [Related]  

  • 18. Physician-industry relations--will fewer gifts make a difference?
    Steinbrook R
    N Engl J Med; 2009 Feb; 360(6):557-9. PubMed ID: 19196671
    [No Abstract]   [Full Text] [Related]  

  • 19. Who rules the great Indian drug bazaar?
    Roy N
    Indian J Med Ethics; 2004; 1(1):2-3. PubMed ID: 16370060
    [No Abstract]   [Full Text] [Related]  

  • 20. Industry-to-physician marketing and the cost of prescription drugs.
    Chiong W
    Am J Bioeth; 2003; 3(3):W28-W29. PubMed ID: 14594480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.